A carregar...
Hemodynamic effects of ambrisentan-tadalafil combination therapy on progressive portopulmonary hypertension
Intravenous epoprostenol is recommended for World Health Organization functional class (WHO-FC) IV patients with pulmonary arterial hypertension (PAH) in the latest guidelines. However, in portopulmonary hypertension (PoPH) patients, advanced liver dysfunction and/or thrombocytopenia often makes the...
Na minha lista:
| Publicado no: | World J Hepatol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243157/ https://ncbi.nlm.nih.gov/pubmed/25429321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v6.i11.825 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|